BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsuda K, Yamanaka K, Kitagawa H, Akeda T, Naka M, Niwa K, Nakanishi T, Kakeda M, Gabazza EC, Mizutani H. Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of naïve T cells into cytokine-producing mature T cells. PLoS One 2012;7:e31465. [PMID: 22359594 DOI: 10.1371/journal.pone.0031465] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Balato A, Paoletti I, De Gregorio V, Cantelli M, Ayala F, Donnarumma G. Tacrolimus does not alter the production of several cytokines and antimicrobial peptide in Malassezia furfur -infected-keratinocytes. Mycoses 2014;57:176-83. [DOI: 10.1111/myc.12140] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
2 Kupetsky EA, Mathers AR, Ferris LK. Anti-cytokine therapy in the treatment of psoriasis. Cytokine 2013;61:704-12. [DOI: 10.1016/j.cyto.2012.12.027] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
3 Erickson S, Nahmias Z, Rosman IS, Kim BS. Immunomodulating Agents as Antipruritics. Dermatologic Clinics 2018;36:325-34. [DOI: 10.1016/j.det.2018.02.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
4 Suárez-fariñas M, Ungar B, Correa da Rosa J, Ewald DA, Rozenblit M, Gonzalez J, Xu H, Zheng X, Peng X, Estrada YD, Dillon SR, Krueger JG, Guttman-yassky E. RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications. Journal of Allergy and Clinical Immunology 2015;135:1218-27. [DOI: 10.1016/j.jaci.2015.03.003] [Cited by in Crossref: 144] [Cited by in F6Publishing: 141] [Article Influence: 20.6] [Reference Citation Analysis]
5 Park YJ, Yoo SA, Kim M, Kim WU. The Role of Calcium-Calcineurin-NFAT Signaling Pathway in Health and Autoimmune Diseases. Front Immunol 2020;11:195. [PMID: 32210952 DOI: 10.3389/fimmu.2020.00195] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 18.5] [Reference Citation Analysis]
6 Merino D, San Segundo D, Medina JM, Rodrigo E, Asensio E, Irure J, Fernández-Fresnedo G, Arias MA, López-Hoyos M. Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment. Immunology 2016;148:206-15. [PMID: 26931075 DOI: 10.1111/imm.12603] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
7 Kageyama T, Komori M, Miyamoto K, Ozaki A, Suenaga T, Takahashi R, Kusunoki S, Matsumoto S, Kondo T. Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica. J Neurol 2013;260:627-34. [PMID: 23076828 DOI: 10.1007/s00415-012-6692-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
8 Seneschal J, Duplaine A, Maillard H, Passeron T, Andreu N, Lassalle R, Favary C, Droitcourt C, Taïeb A, Ezzedine K. Efficacy and Safety of Tacrolimus 0.1% for the Treatment of Facial Vitiligo: A Multicenter Randomized, Double-Blinded, Vehicle-Controlled Study. J Invest Dermatol 2021;141:1728-34. [PMID: 33549606 DOI: 10.1016/j.jid.2020.12.028] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Luger T, Amagai M, Dreno B, Dagnelie MA, Liao W, Kabashima K, Schikowski T, Proksch E, Elias PM, Simon M, Simpson E, Grinich E, Schmuth M. Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents. J Dermatol Sci 2021;102:142-57. [PMID: 34116898 DOI: 10.1016/j.jdermsci.2021.04.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nakahara T, Morimoto H, Murakami N, Furue M. Mechanistic insights into topical tacrolimus for the treatment of atopic dermatitis. Pediatr Allergy Immunol 2018;29:233-8. [PMID: 29205511 DOI: 10.1111/pai.12842] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
11 Kim EJ, Lee JG, Kim JY, Song SH, Joo DJ, Huh KH, Kim MS, Kim BS, Kim YS. Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets. Immunology 2017;152:628-37. [PMID: 28758197 DOI: 10.1111/imm.12804] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
12 Lemaître PH, Vokaer B, Charbonnier LM, Iwakura Y, Field KA, Estenne M, Goldman M, Leo O, Remmelink M, Le Moine A. Cyclosporine A drives a Th17- and Th2-mediated posttransplant obliterative airway disease. Am J Transplant 2013;13:611-20. [PMID: 23331973 DOI: 10.1111/ajt.12067] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
13 Andrade PR, Pinheiro RO, Sales AM, Illarramendi X, de Mattos Barbosa MG, Moraes MO, Jardim MR, da Costa Nery JA, Sampaio EP, Sarno EN. Type 1 reaction in leprosy: a model for a better understanding of tissue immunity under an immunopathological condition. Expert Review of Clinical Immunology 2015;11:391-407. [DOI: 10.1586/1744666x.2015.1012501] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
14 Iannitti RG, Carvalho A, Cunha C, De Luca A, Giovannini G, Casagrande A, Zelante T, Vacca C, Fallarino F, Puccetti P, Massi-Benedetti C, Defilippi G, Russo M, Porcaro L, Colombo C, Ratclif L, De Benedictis FM, Romani L. Th17/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines. Am J Respir Crit Care Med 2013;187:609-20. [PMID: 23306541 DOI: 10.1164/rccm.201207-1346OC] [Cited by in Crossref: 59] [Cited by in F6Publishing: 26] [Article Influence: 6.6] [Reference Citation Analysis]
15 Wee YM, Jung JH, Kim YH, Choi MY, Kim YH, Choi DS, Cho MH, Han DJ. Involvement of indirectly allostimulated CD4+CD43highCD45RO+ T cell proliferation in the development of chronic allograft nephropathy. Exp Biol Med (Maywood) 2016;241:1217-28. [PMID: 26350952 DOI: 10.1177/1535370215601522] [Reference Citation Analysis]
16 Kim EJ, Kim JY, Choi HY, Lee H, Lee J, Kim MS, Kim YS, Huh KH, Kim BS. Systemic Immunomodulatory Effects of Combinatorial Treatment of Thalidomide and Dexamethasone on T Cells and Other Immune Cells. Yonsei Med J 2021;62:137-48. [PMID: 33527793 DOI: 10.3349/ymj.2021.62.2.137] [Reference Citation Analysis]
17 Rahimian R, Béland LC, Kriz J. Galectin-3: mediator of microglia responses in injured brain. Drug Discov Today 2018;23:375-81. [PMID: 29133191 DOI: 10.1016/j.drudis.2017.11.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
18 Martins AM, Ascenso A, Ribeiro HM, Marto J. Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs. Mol Neurobiol 2020;57:2391-419. [DOI: 10.1007/s12035-020-01889-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
19 Guttman-Yassky E, Bissonnette R, Ungar B, Suárez-Fariñas M, Ardeleanu M, Esaki H, Suprun M, Estrada Y, Xu H, Peng X, Silverberg JI, Menter A, Krueger JG, Zhang R, Chaudhry U, Swanson B, Graham NMH, Pirozzi G, Yancopoulos GD, D Hamilton JD. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis. J Allergy Clin Immunol 2019;143:155-72. [PMID: 30194992 DOI: 10.1016/j.jaci.2018.08.022] [Cited by in Crossref: 176] [Cited by in F6Publishing: 151] [Article Influence: 44.0] [Reference Citation Analysis]
20 Takanashi S, Kaneko Y, Takeuchi T. Effectiveness of tacrolimus on IgG4-related disease. Mod Rheumatol 2019;29:892-4. [PMID: 30285576 DOI: 10.1080/14397595.2018.1532560] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
21 Espinosa JR, Samy KP, Kirk AD. Memory T cells in organ transplantation: progress and challenges. Nat Rev Nephrol 2016;12:339-47. [PMID: 26923209 DOI: 10.1038/nrneph.2016.9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
22 Roberts MB, Fishman JA. Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the "Net State of Immunosuppression". Clin Infect Dis 2020:ciaa1189. [PMID: 32803228 DOI: 10.1093/cid/ciaa1189] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
23 Tsuda K, Yamanaka K, Kondo M, Matsubara K, Sasaki R, Tomimoto H, Gabazza EC, Mizutani H. Ustekinumab improves psoriasis without altering T cell cytokine production, differentiation, and T cell receptor repertoire diversity. PLoS One 2012;7:e51819. [PMID: 23251632 DOI: 10.1371/journal.pone.0051819] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
24 Steiner S, Daniel C, Fischer A, Atreya I, Hirschmann S, Waldner M, Neumann H, Neurath M, Atreya R, Weigmann B. Cyclosporine A regulates pro-inflammatory cytokine production in ulcerative colitis. Arch Immunol Ther Exp (Warsz). 2015;63:53-63. [PMID: 25155925 DOI: 10.1007/s00005-014-0309-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
25 Steines L, Poth H, Schuster A, Amann K, Banas B, Bergler T. Disruption of Tfh:B Cell Interactions Prevents Antibody-Mediated Rejection in a Kidney Transplant Model in Rats: Impact of Calcineurin Inhibitor Dose. Front Immunol 2021;12:657894. [PMID: 34135891 DOI: 10.3389/fimmu.2021.657894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Rovin BH, Solomons N, Pendergraft WF, Dooley MA, Tumlin J, Romero-diaz J, Lysenko L, Navarra SV, Huizinga RB, Adzerikho I, Mikhailova E, Mitkovskaya N, Pimanov S, Soroka N, Bogov BI, Deliyska B, Ikonomov V, Tilkiyan E, Almeida R, Jimenez F, Teran F, Tchokhonelidze I, Tsiskarishvili N, Herrera Mendez M, Chavez Perez NN, Loaeza AR, Gutierrez Urena SR, Romero Diaz J, Araiza Casillas R, Madero Rovalo M, Niemczyk S, Sokalski A, Wiecek A, Klinger M, Bugrova OV, Chernykh TM, Kameneva TR, Lysenko LV, Raskina TA, Reshetko OV, Vezikova NN, Kropotina TV, Maksudova AN, Marasaev V, Dobronravov VA, Gordeev I, Essaian AM, Frolov A, Jelacic R, Jovanovic D, Mitic B, Pekovic G, Radovic M, Radunovic G, Carreira P, Diaz Gonzalez F, Fulladosa X, Ucar E, De Silva S, Herath C, Hewageegana A, Nazar ALM, Wazil A, Dudar I, Godlevska O, Korneyeva S, Vasylets V, Sydor N, Kolesnyk M, Parikh SV, Olsen N, Ginzler EM, Tumlin JA, Saxena A, Saxena R, Lafayette RA, Pendergraft WF, Podoll AS, Arrey-mensah AA, Bubb M, Grossman J, Oporta AI, Nami A, Rahman MM, Haq SA, Chan TMD, Temy MMY, Gomez HMP, Bermas J, Reyes BH, Hao LT, Roberto LC, Amante E, Navarra SV, Lanzon AE, Choe J, Kang TY, Kim YS, Lee S, Lee JS, Jun JCC, Vasudevan A, Luo S, Cheng T, Satirapoj B, Noppakun K. A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis. Kidney International 2019;95:219-31. [DOI: 10.1016/j.kint.2018.08.025] [Cited by in Crossref: 90] [Cited by in F6Publishing: 63] [Article Influence: 30.0] [Reference Citation Analysis]
27 de Bruin-weller M, Thaçi D, Smith C, Reich K, Cork M, Radin A, Zhang Q, Akinlade B, Gadkari A, Eckert L, Hultsch T, Chen Z, Pirozzi G, Graham N, Shumel B. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t. Br J Dermatol 2018;178:1083-101. [DOI: 10.1111/bjd.16156] [Cited by in Crossref: 185] [Cited by in F6Publishing: 154] [Article Influence: 46.3] [Reference Citation Analysis]
28 Dowell AC, Haigh TA, Ryan GB, Turner JE, Long HM, Taylor GS. Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors. PLoS Pathog 2021;17:e1010137. [PMID: 34882759 DOI: 10.1371/journal.ppat.1010137] [Reference Citation Analysis]
29 Varelias A, Gartlan KH, Kreijveld E, Olver SD, Lor M, Kuns RD, Lineburg KE, Teal BE, Raffelt NC, Cheong M, Alexander KA, Koyama M, Markey KA, Sturgeon E, Leach J, Reddy P, Kennedy GA, Yanik GA, Blazar BR, Tey SK, Clouston AD, MacDonald KP, Cooke KR, Hill GR. Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation. Blood 2015;125:2435-44. [PMID: 25673640 DOI: 10.1182/blood-2014-07-590232] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 7.4] [Reference Citation Analysis]
30 [DOI: 10.1101/2021.04.06.21254963] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Wolach O, Kuijpers T, Ben-Ari J, Gavrieli R, Feinstein-Goren N, Alders M, Garty BZ, Wolach B. Variable clinical expressivity of STAT3 mutation in hyperimmunoglobulin E syndrome: genetic and clinical studies of six patients. J Clin Immunol 2014;34:163-70. [PMID: 24452316 DOI: 10.1007/s10875-014-9988-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
32 Hefazi M, Bolivar-Wagers S, Blazar BR. Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges. Int J Mol Sci 2021;22:9676. [PMID: 34575843 DOI: 10.3390/ijms22189676] [Reference Citation Analysis]
33 Almaani S, Meara A, Rovin BH. Update on Lupus Nephritis. Clin J Am Soc Nephrol. 2017;12:825-835. [PMID: 27821390 DOI: 10.2215/cjn.05780616] [Cited by in Crossref: 291] [Cited by in F6Publishing: 137] [Article Influence: 48.5] [Reference Citation Analysis]
34 Alberca RW, Benard G, Alberca GGF, Sato MN. SARS-CoV-2 infection in liver transplant recipients: A complex relationship. World J Gastroenterol 2021; 27(44): 7734-7738 [PMID: 34908810 DOI: 10.3748/wjg.v27.i44.7734] [Reference Citation Analysis]
35 An G. Introduction of a Framework for Dynamic Knowledge Representation of the Control Structure of Transplant Immunology: Employing the Power of Abstraction with a Solid Organ Transplant Agent-Based Model. Front Immunol 2015;6:561. [PMID: 26594211 DOI: 10.3389/fimmu.2015.00561] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
36 Oh BR, Chen P, Nidetz R, McHugh W, Fu J, Shanley TP, Cornell TT, Kurabayashi K. Multiplexed Nanoplasmonic Temporal Profiling of T-Cell Response under Immunomodulatory Agent Exposure. ACS Sens 2016;1:941-8. [PMID: 27478873 DOI: 10.1021/acssensors.6b00240] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
37 Cowan M, Chon WJ, Desai A, Andrews S, Bai Y, Veguilla V, Katz JM, Josephson MA, Wilson PC, Sciammas R. Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients. Transplantation. 2014;97:846-853. [PMID: 24366008 DOI: 10.1097/01.tp.0000438024.10375.2d] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
38 Amini L, Wagner DL, Rössler U, Zarrinrad G, Wagner LF, Vollmer T, Wendering DJ, Kornak U, Volk HD, Reinke P, Schmueck-Henneresse M. CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients. Mol Ther 2021;29:32-46. [PMID: 32956624 DOI: 10.1016/j.ymthe.2020.09.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 van den Heuvel H, van der Meer-prins EM, van Miert PP, Zhang X, Anholts JD, Claas FH. Infection with a virus generates a polyclonal immune response with broad alloreactive potential. Human Immunology 2019;80:97-102. [DOI: 10.1016/j.humimm.2018.10.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Khattri S, Shemer A, Rozenblit M, Dhingra N, Czarnowicki T, Finney R, Gilleaudeau P, Sullivan-Whalen M, Zheng X, Xu H, Cardinale I, de Guzman Strong C, Gonzalez J, Suárez-Fariñas M, Krueger JG, Guttman-Yassky E. Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology. J Allergy Clin Immunol 2014;133:1626-34. [PMID: 24786238 DOI: 10.1016/j.jaci.2014.03.003] [Cited by in Crossref: 105] [Cited by in F6Publishing: 96] [Article Influence: 13.1] [Reference Citation Analysis]
41 Picardo M, Dell'anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, Taieb A. Vitiligo. Nat Rev Dis Primers 2015;1. [DOI: 10.1038/nrdp.2015.11] [Cited by in Crossref: 101] [Cited by in F6Publishing: 88] [Article Influence: 14.4] [Reference Citation Analysis]
42 Sattler A, Schrezenmeier E, Weber UA, Potekhin A, Bachmann F, Straub-Hohenbleicher H, Budde K, Storz E, Proß V, Bergmann Y, Thole LM, Tizian C, Hölsken O, Diefenbach A, Schrezenmeier H, Jahrsdörfer B, Zemojtel T, Jechow K, Conrad C, Lukassen S, Stauch D, Lachmann N, Choi M, Halleck F, Kotsch K. Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients. J Clin Invest 2021;131:150175. [PMID: 34101623 DOI: 10.1172/JCI150175] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
43 Ortiz YM, Arias LF, Álvarez CM, García LF. Memory phenotype and polyfunctional T cells in kidney transplant patients. Transplant Immunology 2013;28:127-37. [DOI: 10.1016/j.trim.2013.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
44 Hu Y, Guo J, Yin L, Tu J, Yin Z. Tacrolimus Inhibits TNF-α/IL-17A-Produced pro-Inflammatory Effect on Human Keratinocytes by Regulating IκBζ. Inflammation 2020;43:692-700. [DOI: 10.1007/s10753-019-01151-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Cangemi M, Montico B, Faè DA, Steffan A, Dolcetti R. Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients. Front Oncol 2019;9:160. [PMID: 30972289 DOI: 10.3389/fonc.2019.00160] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
46 Siegl C, König-schuster M, Nakowitsch S, Koller C, Graf P, Unger-manhart N, Schindlegger Y, Kirchoff N, Knecht C, Prieschl-grassauer E, Sipos W. Pharmacokinetics of topically applied tacrolimus dissolved in Marinosolv, a novel aqueous eye drop formulation. European Journal of Pharmaceutics and Biopharmaceutics 2019;134:88-95. [DOI: 10.1016/j.ejpb.2018.11.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
47 Keyhanmehr N, Motedayyen H, Eskandari N. The Effects of Silymarin and Cyclosporine A on the Proliferation and Cytokine Production of Regulatory T Cells. Immunological Investigations 2019;48:533-48. [DOI: 10.1080/08820139.2019.1571506] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
48 Abikhair M, Mitsui H, Yanofsky V, Roudiani N, Ovits C, Bryan T, Oberyszyn TM, Tober KL, Gonzalez J, Krueger JG, Felsen D, Carucci JA. Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22. JCI Insight 2016;1:e86434. [PMID: 27699266 DOI: 10.1172/jci.insight.86434] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
49 Chen DL, Wang X, Yamamoto S, Carpenter D, Engle JT, Li W, Lin X, Kreisel D, Krupnick AS, Huang HJ. Increased T cell glucose uptake reflects acute rejection in lung grafts. Am J Transplant. 2013;13:2540-2549. [PMID: 23927673 DOI: 10.1111/ajt.12389] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
50 Zhang T, Li Z, Liu T, Li S, Gao H, Wei C, Shi W. Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment. PLoS One 2018;13:e0196571. [PMID: 29734357 DOI: 10.1371/journal.pone.0196571] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Alam MS, Gaida MM, Ogawa Y, Kolios AG, Lasitschka F, Ashwell JD. Counter-regulation of T cell effector function by differentially activated p38. J Exp Med 2014;211:1257-70. [PMID: 24863062 DOI: 10.1084/jem.20131917] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
52 Schlüter-Vorberg L, Coors A. Impact of an immunosuppressive human pharmaceutical on the interaction of a bacterial parasite and its invertebrate host. Aquat Toxicol 2019;206:91-101. [PMID: 30468978 DOI: 10.1016/j.aquatox.2018.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Molyvdas A, Matalon S. Cyclosporine: an old weapon in the fight against coronaviruses. Eur Respir J 2020;56:2002484. [PMID: 32732332 DOI: 10.1183/13993003.02484-2020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
54 Cormack S, Mohammed A, Panahi P, Das R, Steel AJ, Chadwick T, Bryant A, Egred M, Stellos K, Spyridopoulos I; CAPRI investigators. Effect of ciclosporin on safety, lymphocyte kinetics and left ventricular remodelling in acute myocardial infarction. Br J Clin Pharmacol 2020;86:1387-97. [PMID: 32067256 DOI: 10.1111/bcp.14252] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
55 Tramsen L, Schmidt S, Roeger F, Schubert R, Salzmann-Manrique E, Latgé JP, Klingebiel T, Lehrnbecher T. Immunosuppressive compounds exhibit particular effects on functional properties of human anti-Aspergillus Th1 cells. Infect Immun 2014;82:2649-56. [PMID: 24711569 DOI: 10.1128/IAI.01700-14] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
56 Nash A, Samoylova M, Leuthner T, Zhu M, Lin L, Meyer JN, Brennan TV. Effects of Immunosuppressive Medications on Mitochondrial Function. J Surg Res 2020;249:50-7. [PMID: 31918330 DOI: 10.1016/j.jss.2019.12.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
57 Ueno KI, Shimojima Y, Kishida D, Sekijima Y, Ikeda SI. Advantage of administering tacrolimus for improving prognosis of patients with polymyositis and dermatomyositis. Int J Rheum Dis 2016;19:1322-30. [PMID: 27457756 DOI: 10.1111/1756-185X.12931] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
58 Parikh SV, Rovin BH. Current and Emerging Therapies for Lupus Nephritis. J Am Soc Nephrol 2016;27:2929-39. [PMID: 27283496 DOI: 10.1681/ASN.2016040415] [Cited by in Crossref: 44] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
59 Maucher M, Srour M, Danhof S, Einsele H, Hudecek M, Yakoub-Agha I. Current Limitations and Perspectives of Chimeric Antigen Receptor-T-Cells in Acute Myeloid Leukemia. Cancers (Basel) 2021;13:6157. [PMID: 34944782 DOI: 10.3390/cancers13246157] [Reference Citation Analysis]
60 Jung J, Overgaard NH, Burke MT, Isbel N, Frazer IH, Simpson F, Wells JW. Does the nature of residual immune function explain the differential risk of non-melanoma skin cancer development in immunosuppressed organ transplant recipients?: Immunosuppressive regimen influences NMSC risk. Int J Cancer 2016;138:281-92. [DOI: 10.1002/ijc.29450] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
61 Motta A, Zhan Q, Larson A, Lerman M, Woo SB, Soiffer RJ, Murphy GF, Treister NS. Immunohistopathological characterization and the impact of topical immunomodulatory therapy in oral chronic graft-versus-host disease: A pilot study. Oral Dis 2018;24:580-90. [PMID: 29197137 DOI: 10.1111/odi.12813] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
62 Kamei H, Onishi Y, Nakamura T, Ishigami M, Hamajima N. Role of cytokine gene polymorphisms in acute and chronic kidney disease following liver transplantation. Hepatol Int 2016;10:665-72. [PMID: 27003899 DOI: 10.1007/s12072-016-9721-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
63 Kurata Y, Kuzuya T, Miwa Y, Iwasaki K, Haneda M, Amioka K, Yamada K, Watarai Y, Katayama A, Uchida K, Kobayashi T. Clinical relevance of post-transplant pharmacodynamic analysis of cyclosporine in renal transplantation. International Immunopharmacology 2014;22:384-91. [DOI: 10.1016/j.intimp.2014.07.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
64 Zhang QQ, Xu P, Sun C, Liu LJ, Jiang WW. Topical tacrolimus with different frequency for exfoliative cheilitis: a pilot study. J Dermatolog Treat 2020;:1-5. [PMID: 32431191 DOI: 10.1080/09546634.2020.1771258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Meng JW, Song JH. Association between interleukin-2, interleukin-10, secretory immunoglobulin A and immunoglobulin G expression in vaginal fluid and human papilloma virus outcome in patients with cervical lesions. Oncol Lett 2019;18:5543-8. [PMID: 31612062 DOI: 10.3892/ol.2019.10897] [Reference Citation Analysis]